BeyondSpring, Inc. - Ordinary Shares (BYSI): Price and Financial Metrics
BYSI Price/Volume Stats
| Current price | $1.70 | 52-week high | $4.00 |
| Prev. close | $1.71 | 52-week low | $1.05 |
| Day low | $1.61 | Volume | 17,700 |
| Day high | $1.88 | Avg. volume | 13,355 |
| 50-day MA | $1.68 | Dividend yield | N/A |
| 200-day MA | $2.08 | Market Cap | 66.35M |
BYSI Stock Price Chart Interactive Chart >
BeyondSpring, Inc. - Ordinary Shares (BYSI) Company Bio
BeyondSpring is a global clinical stage biopharmaceutical company developing innovative immuno-oncology cancer therapies. The co is advancing its lead asset, Plinabulin, into a Phase 3 clinical trial as a direct anticancer agent in non-small cell lung cancer and a Phase 2/3 clinical trial in the prevention of chemotherapy-induced Neutropenia.
BYSI Price Returns
| 1-mo | N/A |
| 3-mo | -2.30% |
| 6-mo | -11.46% |
| 1-year | 44.07% |
| 3-year | -35.85% |
| 5-year | -90.39% |
| YTD | 4.29% |
| 2024 | 81.11% |
| 2023 | -52.13% |
| 2022 | -58.50% |
| 2021 | -62.87% |
| 2020 | -21.29% |
Loading social stream, please wait...